Skip to main content
. 2021 Mar 22;13(6):7828–7845. doi: 10.18632/aging.202858

Table 1. The rate of oxidative phosphorylation in IFM from young and aged mice with or without metformin treatment.

Mice 3 mo. 24 mo.
Groups Vehicle (n=13) Metformin (n=5) Vehicle (n=11) Metformin (n=5)
Complex I substrates: glutamate + malate
State 3 (nAO/min/mg) 356±13 367±14 271±13* 337±22†
State 4 (nAO/min/mg) 58±3 58±5 48±1* 58±3†
RCR 6.3±0.2 6.6±0.5 5.7±0.2 5.9±0.5
2 mM ADP (nAO/min/mg) 481±17 487±29 318±19* 397±32†
Complex II substrates: Succinate + rotenone
State 3 (nAO/min/mg) 860±30 735±13* 779±34 847±30
State 4 (nAO/min/mg) 256±12 226±11 212±8* 218±8
RCR 3.4±0.1 3.3±0.1 3.7±0.1 3.9±0.1
2 mM ADP (nAO/min/mg) 849±29 746±19* 769±34 788±32

Mean ± SEM. *p<0.05 vs. 3 mo. Vehicle, †p<0.05 vs. 24 mo. Vehicle.